North America Bioinformatics Market is segmented By Type (Knowledge Management Tools, and Bioinformatics Software and Services) By Application (Genomics & Drug Development, Proteomics, Transcriptomics and Others) By End-User (Research and Academic Institutes, Clinical Research Organization, Biotech and Pharmaceutical Companies, and Others) and By Country (U.S., Canada, and New Mexico) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
North America Bioinformatics Market Overview
The North America Bioinformatics Market is expected to grow at a high CAGR during the forecast period 2023-2030.
Bioinformatics is a branch of science that integrates computer programming, big data, and Molecular Biology to help scientists comprehend and detect patterns in biological data. It is especially valuable in genome research and DNA sequencing since it helps scientists to arrange vast volumes of data.
There are several fields of Biology to specialize in, ranging from genetics to toxicology to mycology and radiobiology. Bioinformatics is one of the fascinating topics that allows you to find, assess, store, and retrieve biological information. As an interdisciplinary topic of research, it combines applications of Computer Science, Statistics, and Biology to create software applications for interpreting biological data such as DNA sequencing, protein analysis, evolutionary genetics, and so on.
Important bioinformatics choices on drug development will be made in the future by individuals who not only understand biology but can also utilize bioinformatics tools and the information they release to create hypotheses and find excellent targets.
North America Bioinformatics Market Summary and Scope
|
Metrics |
Details |
|
CAGR |
High |
|
Size Available for Years |
2021-2030 |
|
Forecast Period |
2023-2030 |
|
Data Availability |
Value (US$) |
|
Segments Covered |
Type, Application, and End-User |
|
Countries Covered |
U.S., Canada, and New Mexico |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report Request for Sample
North America Bioinformatics Market Drivers
Reduced Cost of Genetic Sequencing Per Base
Oral health is a crucial element of preserving the health of your gums, teeth, and the oral-facial system, which enables you to talk, eat, and smile. According to a World Health Organization research released on March 25th, 2020, around 2.3 billion individuals worldwide suffer from caries of a permanent tooth, with approximately 530 million children suffering from caries of the primary tooth. Periodontal disease is common in all age groups in North America. As a result of increased periodontal dental problems, the availability and use of intraoral scanners are expected to drive market growth.
Increasing Demand for Bioinformatics
Next-generation sequencing (NGS) is evolving as a powerful tool for providing a deeper and more precise insight into the molecular underpinnings of individual tumors and specific receptors as genomics-focused pharmacology continues to play a greater role in the treatment of various chronic diseases, particularly cancer. Informatics is critical in biological research because it involves biologists who study programming, computer programmers, mathematicians, or database administrators who understand the basics of biology.
North America Bioinformatics Market Opportunities
Product Developments in Recent Years Have Created Lucrative Opportunities
The growth curve for bioinformatics market clinical applications is on the rise, as existing applications acquire traction and new ones are gaining momentum. Product development in recent years has aided market growth. This also demonstrates the regulatory agency's support for letting these products on the market.
For instance, Agilent Technologies, Inc. published Sure Select Human All Exon V8 in June 2021, which delivers particular content and current coverage of protein-coding regions from Refuses, CCDS, and GENCODE. It also contains difficult-to-capture exons and the TERT promoter, which are overlooked by competing exomes.
Product development in recent years has shown the promise of these technologies, and firms operating in this market are attempting to introduce more sophisticated products, which is projected to generate a profitable opportunity for market growth throughout the projection period.
North America Bioinformatics Market Challenges
Bioinformatics technology can analyze huge amounts of biological data. This capability improves diagnostic screening by facilitating computational tools for the arrangement and interpretation of biological data. The implementation of these strong technologies in a clinical laboratory presents a difficulty due to the breadth, quantity, and medico-technical implications of the data.
North America Bioinformatics Market Segmentation Analysis
The North America bioinformatics market is segmented by type, application, and end-user.
Type Insights
Genomics Segment Accounted for the Largest Market Share due to its Wide Range of Applications
The genomics segment is expected to dominate the bioinformatics market due to advances in sequencing technology, decreased prices, and rising applications in personalized medicine, disease genomics, agricultural genomics, population genetics, and other areas.
Genomics is vital in personalizing medical treatments, determining the genetic basis of illnesses, assessing population trends, and overcoming large data challenges. Because of its wide impact and rising need for genetic data processing, the genomics segment is expected to continue dominating the North America bioinformatics market.
North America Bioinformatics Market Key Development
- In March 2022, Thermo Fisher Scientific Inc introduced the CE-IVD Marked Next-Generation Sequencing (NGS) Instrument for Use in Clinical Labs. The CE-IVD Marked Next-Generation Sequencing Instrument combines diagnostic testing and clinical research on a single platform. The instrument's debut resulted in the addition of a new product to the product line as well as the distribution of the NGS instrument, which is projected to improve product revenue.
North America Bioinformatics Market Regional Synopsis
The countries covered in the North America bioinformatics market are U.S., Canada, and New Mexico.
United States Dominating the North American Bioinformatics Market
The United States is predicted to lead the market owing to an increase in the frequency of periodontal diseases, a rise in medical tourism, a growth of technological innovations in bioinformatics, and an increase in R&D activities.
North America Bioinformatics Market Competitive Landscape
The major companies contributing to the North America bioinformatics market growth include Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS., BGI, Eurofins Scientific, Water Corporation, Partek Incorporated, DNASTAR, Dassault Systèmes, Bayer AG, DNANEXUS, INC., PerkinElmer Inc., Seven Bridges Genomics, Quest Diagnostics Incorporated., AstridBio Technologies Inc., BioBam, and GenoFAB, Inc.
